{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:52:55Z","timestamp":1791996775889,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001254","name":"Ipsen Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bone.2026.117982","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:06:01Z","timestamp":1781798761000},"page":"117982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of the Fibrodysplasia Ossificans Progressiva FLare EXperience Revised (FOP-FLEX-R\u00a9) Questionnaire: A Patient-Reported Outcome Measure"],"prefix":"10.1016","volume":"212","author":[{"given":"Robert J.","family":"Pignolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Al Mukaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Brova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Olonilua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"LaBranche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cori Ann","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine A.","family":"Boing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Karimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyinkan","family":"Solanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick S.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bone.2026.117982_bb0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13023-017-0674-5","article-title":"Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases","volume":"12","author":"Baujat","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bone.2026.117982_bb0010","author":"OMIM"},{"issue":"3","key":"10.1016\/j.bone.2026.117982_bb0015","doi-asserted-by":"crossref","first-page":"053","DOI":"10.7324\/JAPS.2023.130303","article-title":"A literature review of HRQoL and prevalence of fibrodysplasia ossificans progressiva","volume":"13","author":"Mahapatra","year":"2023","journal-title":"J. Appl. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.bone.2026.117982_bb0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1302\/0301-620X.64B1.7068725","article-title":"Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients","volume":"64","author":"Connor","year":"1982","journal-title":"J. Bone Joint Surg. (Br.)"},{"issue":"2","key":"10.1016\/j.bone.2026.117982_bb0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2106\/00004623-199302000-00009","article-title":"The histopathology of fibrodysplasia ossificans progressiva. An endochondral process","volume":"75","author":"Kaplan","year":"1993","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2026.117982_bb0030","first-page":"238","article-title":"Radiographic and scintigraphic features of modeling and remodeling in the heterotopic skeleton of patients who have fibrodysplasia ossificans progressiva","volume":"304","author":"Kaplan","year":"1994","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"3","key":"10.1016\/j.bone.2026.117982_bb0035","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2106\/JBJS.I.00705","article-title":"Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva","volume":"92","author":"Kaplan","year":"2010","journal-title":"JBJS"},{"issue":"6","key":"10.1016\/j.bone.2026.117982_bb0040","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1007\/s12325-022-02096-3","article-title":"\u201cI can\u2019t take off my shirt or do my own hair\u201d-a qualitative investigation of the symptoms and impact experience of children and adolescents with Fibrodysplasia Ossificans Progressiva (FOP)","volume":"39","author":"Markowitz","year":"2022","journal-title":"Adv. Ther."},{"issue":"6","key":"10.1016\/j.bone.2026.117982_bb0045","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/09638288.2017.1405083","article-title":"Longitudinal study of the activities of daily living and quality of life in Japanese patients with fibrodysplasia ossificans progressiva","volume":"41","author":"Nakahara","year":"2019","journal-title":"Disabil. Rehabil."},{"issue":"3","key":"10.1016\/j.bone.2026.117982_bb0050","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbmr.2728","article-title":"The natural history of flare-ups in Fibrodysplasia Ossificans Progressiva (FOP): a comprehensive global assessment","volume":"31","author":"Pignolo","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.bone.2026.117982_bb0055","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.gim.2022.08.013","article-title":"The natural history of fibrodysplasia ossificans progressiva: a prospective, global 36-month study","volume":"24","author":"Pignolo","year":"2022","journal-title":"Genet. Med."},{"issue":"10","key":"10.1016\/j.bone.2026.117982_bb0060","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/jbmr.4655","article-title":"Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): results of a randomized, placebo-controlled, double-blind phase 2 trial","volume":"37","author":"Pignolo","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2026.117982_bb0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jbmr.4762","article-title":"Reduction of new heterotopic ossification (HO) in the open-label, phase 3 MOVE trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP)","volume":"38","author":"Pignolo","year":"2023","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117982_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bone.2017.04.015","article-title":"A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP)","volume":"101","author":"Kaplan","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.117982_bb0075","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bone.2017.06.005","article-title":"Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP)","volume":"109","author":"Kaplan","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.117982_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116642","article-title":"The Fibrodysplasia Ossificans Progressiva Physical Function Questionnaire (FOP-PFQ): a patient-reported, disease-specific measure","volume":"168","author":"Pignolo","year":"2023","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2026.117982_bb0085","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/bcp.13777","article-title":"Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP)","volume":"85","author":"Hsiao","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bone.2026.117982_bb0090","doi-asserted-by":"crossref","DOI":"10.1007\/s12325-026-03506-6","article-title":"Content validation of the flares diary: a qualitative analysis of the flares experience within the Fibrodysplasia Ossificans Progressiva (FOP) population","author":"Baldasaro","year":"2026","journal-title":"Adv. Ther."},{"issue":"8","key":"10.1016\/j.bone.2026.117982_bb0095","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","article-title":"Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1\u2014eliciting concepts for a new PRO instrument","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.bone.2026.117982_bb0100","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","article-title":"Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2\u2014assessing respondent understanding","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.bone.2026.117982_bb0105","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1185\/03007990902774765","article-title":"Optimal recall periods for patient-reported outcomes: challenges and potential solutions","volume":"25","author":"Stull","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bone.2026.117982_bb0110","author":"US Department of Health and Human Services, F.a.D.A., Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health"},{"key":"10.1016\/j.bone.2026.117982_bb0115","author":"US Department of Health and Human Services FaDA, C.f.D.E.a.R., Center for Biologics Evaluation and Research"},{"key":"10.1016\/j.bone.2026.117982_bb0120","author":"US Department of Health and Human Services, F.a.D.A., Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health"},{"issue":"12","key":"10.1016\/j.bone.2026.117982_bb0125","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1037\/pas0000626","article-title":"Constructing validity: new developments in creating objective measuring instruments","volume":"31","author":"Clark","year":"2019","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.bone.2026.117982_bb0130","author":"American Educational Research Association, A.P.A., National Council on Measurement in Education, & Joint Committee on Standards for Educational and Psychological Testing (AERA, APA, & NCME)"},{"issue":"1","key":"10.1016\/j.bone.2026.117982_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","article-title":"Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes","volume":"273","author":"Wilson","year":"1995","journal-title":"Jama"},{"key":"10.1016\/j.bone.2026.117982_bb0140","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziaf150","article-title":"Medical guidelines for fibrodysplasia ossificans progressiva","volume":"9","author":"Kaplan","year":"2025","journal-title":"JBMR Plus"},{"key":"10.1016\/j.bone.2026.117982_bb0145","author":"US Food and Drug Administration"},{"key":"10.1016\/j.bone.2026.117982_bb0150","author":"Russian State Register of Medicines"},{"key":"10.1016\/j.bone.2026.117982_bb0155","author":"Australian Government Department of Health and Aged Care Therapeutic Goods Administration"},{"key":"10.1016\/j.bone.2026.117982_bb0160","author":"The Drug and Health Product Register, G.o.C"},{"key":"10.1016\/j.bone.2026.117982_bb0165","author":"Ipsen"},{"key":"10.1016\/j.bone.2026.117982_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2024.111617","article-title":"Patient-reported outcomes and measures are under-utilised in advanced therapy medicinal products trials for orphan conditions","volume":"178","author":"Ciuca","year":"2025","journal-title":"J. Clin. Epidemiol."},{"issue":"6","key":"10.1016\/j.bone.2026.117982_bb0175","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40258-023-00827-3","article-title":"The assessment of patient-reported outcomes for the authorisation of medicines in Europe: a review of European public assessment reports from 2017 to 2022","volume":"21","author":"Meregaglia","year":"2023","journal-title":"Appl. Health Econ. Health Policy"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226002085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226002085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:39:19Z","timestamp":1791995959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226002085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":35,"alternative-id":["S8756328226002085"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.117982","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of the Fibrodysplasia Ossificans Progressiva FLare EXperience Revised (FOP-FLEX-R\u00a9) Questionnaire: A Patient-Reported Outcome Measure","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.117982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117982"}}